Contraception Experience among Adolescents with Sickle Cell Disease
Received Date: February 07, 2020; Published Date: February 14, 2020
Purpose: Sickle cell disease has unique impacts on females in their reproductive years. This study evaluated contraception use and knowledge among adolescent female sickle cell disease patients at a hematology clinic. Patients on hydroxyurea were predicted to report higher rates of contraception use than those not using hydroxyurea.
Methods: Female sickle cell disease patients ages 14 to 25 were surveyed regarding their contraception counseling experiences and their contraception knowledge and use.
Results: Of 12 participants, three reported having used contraception. Four reported receiving no contraception counseling. Patients on hydroxyurea did not use contraception more frequently than those not on hydroxyurea.
Conclusions: This study revealed gaps in contraception knowledge and need for better contraception counseling among female sickle cell disease patients. Further research should explore ways to increase contraception use and explore secondary effects among these patients. Collaborative care for these patients may help address all aspects of their care.